KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Net Cash Flow: 2015-2025

Historic Net Cash Flow for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $239.0 million.

  • Medpace Holdings' Net Cash Flow rose 64.96% to $239.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$374.7 million, marking a year-over-year decrease of 166.68%. This contributed to the annual value of $426.5 million for FY2024, which is 97.36% up from last year.
  • Medpace Holdings' Net Cash Flow amounted to $239.0 million in Q3 2025, which was up 160.03% from -$398.1 million recorded in Q2 2025.
  • Over the past 5 years, Medpace Holdings' Net Cash Flow peaked at $239.0 million during Q3 2025, and registered a low of -$398.1 million during Q2 2025.
  • For the 3-year period, Medpace Holdings' Net Cash Flow averaged around $23.0 million, with its median value being $56.5 million (2023).
  • In the last 5 years, Medpace Holdings' Net Cash Flow plummeted by 764.14% in 2022 and then surged by 4,199.56% in 2023.
  • Quarterly analysis of 5 years shows Medpace Holdings' Net Cash Flow stood at $64.2 million in 2021, then crashed by 105.70% to -$3.7 million in 2022, then surged by 4,199.56% to $149.9 million in 2023, then tumbled by 90.33% to $14.5 million in 2024, then spiked by 64.96% to $239.0 million in 2025.
  • Its Net Cash Flow stands at $239.0 million for Q3 2025, versus -$398.1 million for Q2 2025 and -$230.1 million for Q1 2025.